Retinal Screening Redesigned

Optain pairs Resolve™, our FDA-cleared robotic camera, with rapid Optain grading. So simple, it becomes part of every visit. No dilation, no specialist referral, no patient drop-off.

56 dsc00044 (1) 2

01.
Push-button robotic capture: So easy to use, mastered by your team in minutes

02.
Lightweight, portable, no dilation: Engineered for true point-of-care use

03.
Specialist multi-condition grading: Diabetic retinopathy and far beyond

04.
Nine-language patient UI: Reaching every community you serve

05.
Seamless go-live: Integrations with every major EHR; available in all 50 states

Status Quo

<50% of Americans with diabetes complete their annual retinal exam—missed disease, lost sight.

Dilated exams and off-site referrals stall care—meaning patients simply can’t go.

Unused screening gear gathers dust—quality scores and revenue suffer.

With Optain

Everyday use—any staff member can run push-button screening.

Undilated, rapid imaging measured in seconds instead of minutes—keeps clinic schedules on track

Quality scores climb, reimbursements flow, and vision is protected.

Seamless and Secure,
Built for Busy Clinics

Optain drops straight into your existing workflow—no patient data re-entry, and a learning curve measured in minutes, not days.

01.
Capture: Order in your EHR. One tap lets any staff member capture a sharp, undilated 50° image. Wireless encrypted upload to Optain and your EHR

02.
Grade: Licensed Optain graders return a ICD-10-coded report, typically the same day

03.
Act: Referral-ready discrete data + PDF report flow into the chart and quality dashboards

Trusted nationwide, clinics choose Optain

Optain meets patients wherever care happens:
 Health Systems • Primary Care • Health Plans • At-Home Care • FQHCs • Community Events

screen shot 2019 07 28 at 11.20.44 pm 1024x305 1

Our vision: oculomics for everyone

The eyes are the window to the body. Resolve + Optain grading detects diabetic retinopathy, suspect glaucoma, AMD, and many other conditions in a rapid, non-invasive scan that runs anywhere care happens, no extra staff needed.

Our end-to-end oculomics platform brings earlier, easier, and more equitable disease detection to communities care has traditionally left behind.

Connect with AI Healthcare Experts

hbspt.forms.create({ region: 'na1', portalId: '43589183', formId: 'e39e40e6-c293-4c4b-84fd-c36deb78de5e', });

Frequently Asked Questions

Yes—Resolve™ is an FDA-cleared Class II medical device that is used for image capture. Grading is performed by specialist, licensed teleretina graders.

Unlike solutions that screen only for diabetic retinopathy, Optain’s specialist graders detect DR and flag suspected glaucoma, cataracts, macular degeneration, and additional pathologies—reducing the risk of missed comorbid conditions.

Resolve™ is able to speak to patients in nine patient languages: English, Spanish, Portuguese, German, Dutch, Mandarin Chinese, Cantonese Chinese, Vietnamese, and Korean.

Optain has available integrations with Epic, Cerner, athenahealth, Allscripts, and all major EHRs. Other integrations are available for enterprise workflows.

Services align with nationally recognized CPT codes, reimbursed by Medicare, Medicaid, and commercial payers, for immediate ROI.

Optain can drive improvements in HEDIS, MIPS, Stars, and risk adjustment scores, improving both care delivery and financial performance.

Staff can be fully trained in less than an hour. Push-button capture means adoption and usage is consistent at scale.

Retinal Screening Redesigned

Optain pairs Resolve™, our FDA-cleared robotic camera, with rapid Optain grading. So simple, it becomes part of every visit. No dilation, no specialist referral, no patient drop-off.